CN Stock MarketDetailed Quotes

688373 Shanghai Micurx Pharmaceutical

Watchlist
  • 4.88
  • -0.01-0.20%
Trading Jan 9 14:17 CST
3.20BMarket Cap-6.83P/E (TTM)

Shanghai Micurx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Micurx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 251.000M--
--2024/FY-- / 156.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 251.000M--
--2024/FY-- / 156.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----

Unlock Free Earnings Estimates

Shanghai Micurx Pharmaceutical Earnings Reports

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 24, 2024 12:00 ET

  • Shanghai Mengke Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 28, 2024 12:00 ET

  • Summary of the 2024 semi-annual report of Shanghai Mengke Pharmaceutical Co., Ltd.

    Aug 28, 2024 12:00 ET

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 25, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    ZECHENG ELECTRONICS
    837821
    38.46 +28.16%
    HUAWEI DESIGN
    833427
    17.75 +24.13%
    Ji Yao Holding Group
    300108
    1.37 +20.18%
    Shenzhen Bestek Technology
    300822
    23.68 +20.02%
    Shanghai Hajime Advanced Material Technology
    301000
    28.42 +20.02%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 9, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data